The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

類似資料

• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
  著者:: Fox, S, 等
  出版事項: (2011)
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
  著者:: Mele, T, 等
  出版事項: (2010)
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
  著者:: Mele, T, 等
  出版事項: (2010)
• Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer
  著者:: Generali, D, 等
  出版事項: (2007)
• Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
  著者:: Generali, D, 等
  出版事項: (2007)